Granzyme (gzm) A and gzmB have been implicated in Fas-independent nucleolytic and cytolytic processes exerted by cytotoxic T (Tc) cells, but the underlying mechanism(s) remains unclear. In this study, we compare the potential of Tc and natural killer (NK) cells of mice deficient in both gzmA and B (gzmA×B−/−) with those from single knockout mice deficient in gzmA (−/−), gzmB (−/−), or perforin (−/−) to induce nuclear damage and lysis in target cells. With the exception of perforin−/−, all in vitro– and ex vivo–derived Tc and NK cell populations from the mutant strains induced 51Cr-release in target cells at levels and with kinetics similar to those of normal mice. This contrasts with their capacity to induce apoptotic nuclear damage in target cells. In gzmA×B−/− mice, Tc/NK-mediated target cell DNA fragmentation was not observed, even after extended incubation periods (10 h), but was normal in gzmA-deficient and only impaired in gzmB-deficient mice in short-term (2–4 h), but not long-term (4–10 h), nucleolytic assays. This suggests that gzmA and B are critical for Tc/NK granule– mediated nucleolysis, with gzmB being the main contributor, while target cell lysis is due solely to perforin and independent of both proteases.
Article navigation
17 November 1997
Brief Definitive Report|
November 17 1997
In Vitro– and Ex Vivo–derived Cytolytic Leukocytes from Granzyme A × B Double Knockout Mice Are Defective in Granule-mediated Apoptosis but not Lysis of Target Cells
Markus M. Simon,
Markus M. Simon
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Michael Hausmann,
Michael Hausmann
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Thao Tran,
Thao Tran
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Klaus Ebnet,
Klaus Ebnet
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Jürg Tschopp,
Jürg Tschopp
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Ron ThaHla,
Ron ThaHla
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Arno Müllbacher
Arno Müllbacher
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Search for other works by this author on:
Markus M. Simon,
Michael Hausmann,
Thao Tran,
Klaus Ebnet,
Jürg Tschopp,
Ron ThaHla,
Arno Müllbacher
From the *Max-Planck-Institut für Immunbiology, Stübeweg 51, D-79108 Freiburg, Germany; ‡Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and §Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra City, A.C.T. 2601, Australia
Address correspondence to Dr. Markus M. Simon, Max-Planck-Institut für Immunbiologie, Stübeweg 51, D-79108 Freiburg, Germany. Phone: 49-761-5108-533; FAX: 49-761-5108-529; E-mail: [email protected] Klaus Ebnet's present address is Institut für Zellbiologie, ZMBE, D-48149 Münster, Germany.
Received:
August 13 1997
Revision Received:
September 22 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 186 (10): 1781–1786.
Article history
Received:
August 13 1997
Revision Received:
September 22 1997
Citation
Markus M. Simon, Michael Hausmann, Thao Tran, Klaus Ebnet, Jürg Tschopp, Ron ThaHla, Arno Müllbacher; In Vitro– and Ex Vivo–derived Cytolytic Leukocytes from Granzyme A × B Double Knockout Mice Are Defective in Granule-mediated Apoptosis but not Lysis of Target Cells . J Exp Med 17 November 1997; 186 (10): 1781–1786. doi: https://doi.org/10.1084/jem.186.10.1781
Download citation file:
Sign in
Don't already have an account? Register
Suggested Content
Email alerts
Advertisement
